Point of Injury Therapy to Maintain and Stabilize Moderate-Severe Traumatic Brain Injury (TBI) Casualties.
Award amount
$999,986Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- CHROMOLOGIC LLC
- Proposal award date
- 2018-08-27
- Contract end date
- 2021-01-26
- UEI
- D9EVNTKKWLF3
- Solicitation number
- 2017.1
- Topic code
- DHA17-011
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β
- Membrane-based AWE Device (MAWED)
- Ceramic membrane based portable oxygen generator (CEMPOG)
- CRISPR-based Assay for Portable Tropical Infection Diagnosis (CAPTIN-D)
- Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- SanFlow: A Therapeutic Agent for Use in the Field for Traumatic Brain Injury
- Point of Injury Therapy to Maintain and Stabilize Moderate-Severe Traumatic Brain Injury (TBI) Casualties.
- SanFlow: A Therapeutic Agent for Use in the Field for Traumatic Brain Injury
- Cerebral Trauma Recovery (CereTRec) drug delivery system
Research funding history
93 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $49,103,552. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Energy